You just read:

Debiopharm Expands Its Radiopharmaceutical Footprint With an Exclusive In-licensing Agreement of 3B Pharmaceutical's Targeted CAIX Radiotherapy

News provided by

Debiopharm International SA

25 Mar, 2020, 08:00 GMT